ALB and neoplasm: The prepared C/M@Alb NCs exhibited various advantages such as small PS, apt drug loading capacity, greater cellular uptake, dual pH/GSH-responsive drug release, higher intracellular reactive oxygen species (ROS) scavenging ability, extended systemic circulation time, precise tumor targeting, LN accumulation, and a first-rate biosafety.